View Future GrowthMCON Rasayan India 過去の業績過去 基準チェック /16MCON Rasayan Indiaは、平均年間31.3%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間6.7% 23.9%収益成長率で 成長しています。 MCON Rasayan Indiaの自己資本利益率は6.6%であり、純利益率は3.9%です。主要情報31.29%収益成長率21.10%EPS成長率Chemicals 業界の成長17.68%収益成長率23.93%株主資本利益率6.58%ネット・マージン3.94%次回の業績アップデート27 May 2026最近の業績更新お知らせ • May 20MCON Rasayan India Limited to Report Second Half, 2026 Results on May 27, 2026MCON Rasayan India Limited announced that they will report second half, 2026 results on May 27, 2026お知らせ • Nov 07MCON Rasayan India Limited to Report First Half, 2026 Results on Nov 12, 2025MCON Rasayan India Limited announced that they will report first half, 2026 results on Nov 12, 2025Reported Earnings • Aug 23Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹421.3m (up 36% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.Reported Earnings • May 27Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹425.4m (up 37% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.Reported Earnings • Sep 13Full year 2023 earnings released: EPS: ₹2.63 (vs ₹1.29 in FY 2022)Full year 2023 results: EPS: ₹2.63 (up from ₹1.29 in FY 2022). Revenue: ₹310.5m (up 62% from FY 2022). Net income: ₹11.4m (up 129% from FY 2022). Profit margin: 3.7% (up from 2.6% in FY 2022). The increase in margin was driven by higher revenue.Reported Earnings • May 31Full year 2023 earnings releasedFull year 2023 results: Revenue: ₹310.6m (up 62% from FY 2022). Net income: ₹11.4m (up 156% from FY 2022). Profit margin: 3.7% (up from 2.3% in FY 2022). The increase in margin was driven by higher revenue.すべての更新を表示Recent updatesお知らせ • May 20MCON Rasayan India Limited to Report Second Half, 2026 Results on May 27, 2026MCON Rasayan India Limited announced that they will report second half, 2026 results on May 27, 2026New Risk • May 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.9x net interest cover). High level of non-cash earnings (31% accrual ratio). Market cap is less than US$10m (₹410.8m market cap, or US$4.32m). Minor Risk Share price has been volatile over the past 3 months (8.7% average weekly change).Valuation Update With 7 Day Price Move • May 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹56.05, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 29% over the past three years.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹45.70, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.分析記事 • Feb 13MCON Rasayan India (NSE:MCON) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Valuation Update With 7 Day Price Move • Dec 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹72.60, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 65% over the past year.お知らせ • Nov 07MCON Rasayan India Limited to Report First Half, 2026 Results on Nov 12, 2025MCON Rasayan India Limited announced that they will report first half, 2026 results on Nov 12, 2025Valuation Update With 7 Day Price Move • Oct 20Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹63.50, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 56% over the past year.分析記事 • Sep 26Slammed 28% MCON Rasayan India Limited (NSE:MCON) Screens Well Here But There Might Be A CatchTo the annoyance of some shareholders, MCON Rasayan India Limited ( NSE:MCON ) shares are down a considerable 28% in...Valuation Update With 7 Day Price Move • Sep 25Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹61.65, the stock trades at a trailing P/E ratio of 19.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 61% over the past year.分析記事 • Sep 18Here's Why MCON Rasayan India (NSE:MCON) Has A Meaningful Debt BurdenThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...お知らせ • Sep 01MCON Rasayan India Limited, Annual General Meeting, Sep 25, 2025MCON Rasayan India Limited, Annual General Meeting, Sep 25, 2025, at 11:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹77.65, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 56% over the past year.分析記事 • Aug 05Market Cool On MCON Rasayan India Limited's (NSE:MCON) Earnings Pushing Shares 25% LowerUnfortunately for some shareholders, the MCON Rasayan India Limited ( NSE:MCON ) share price has dived 25% in the last...New Risk • Jun 03New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹834.4m (US$9.75m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). High level of non-cash earnings (45% accrual ratio). Market cap is less than US$10m (₹834.4m market cap, or US$9.75m). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding).New Risk • Jun 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (₹924.5m market cap, or US$10.8m).Valuation Update With 7 Day Price Move • May 30Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹126, the stock trades at a trailing P/E ratio of 38.3x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 16% over the past year.New Risk • May 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (₹1.02b market cap, or US$12.0m).Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹153, the stock trades at a trailing P/E ratio of 46.6x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 20% over the past year.Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹145, the stock trades at a trailing P/E ratio of 44x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 17% over the past year.Board Change • Mar 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Tapas Majumdar was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.分析記事 • Feb 07Is MCON Rasayan India (NSE:MCON) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...分析記事 • Dec 25Here's Why We Think MCON Rasayan India (NSE:MCON) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹191, the stock trades at a trailing P/E ratio of 49.9x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 22% over the past year.Valuation Update With 7 Day Price Move • Nov 22Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹158, the stock trades at a trailing P/E ratio of 41.4x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 9.2% over the past year.New Risk • Nov 21New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.11b market cap, or US$13.1m).New Risk • Nov 06New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₹421m (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (30% accrual ratio). Minor Risks High level of debt (97% net debt to equity). Revenue is less than US$5m (₹421m revenue, or US$5.0m). Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹181, the stock trades at a trailing P/E ratio of 51x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 24% over the past year.分析記事 • Oct 12The Price Is Right For MCON Rasayan India Limited (NSE:MCON) Even After Diving 27%The MCON Rasayan India Limited ( NSE:MCON ) share price has fared very poorly over the last month, falling by a...分析記事 • Sep 25Here's Why We Think MCON Rasayan India (NSE:MCON) Is Well Worth WatchingIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Reported Earnings • Aug 23Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹421.3m (up 36% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.お知らせ • Aug 20MCON Rasayan India Limited, Annual General Meeting, Sep 12, 2024MCON Rasayan India Limited, Annual General Meeting, Sep 12, 2024, at 11:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹182, the stock trades at a trailing P/E ratio of 51.3x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 72% over the past year.分析記事 • Jun 23Is MCON Rasayan India (NSE:MCON) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...New Risk • Jun 14New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.8x net interest cover). Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (30% accrual ratio). Minor Risk Market cap is less than US$100m (₹904.6m market cap, or US$10.8m).Reported Earnings • May 27Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹425.4m (up 37% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.分析記事 • May 26MCON Rasayan India Limited (NSE:MCON) Not Lagging Market On Growth Or PricingMCON Rasayan India Limited's ( NSE:MCON ) price-to-earnings (or "P/E") ratio of 62.9x might make it look like a strong...Valuation Update With 7 Day Price Move • May 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹106, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 14% over the past year.New Risk • May 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (₹811.6m market cap, or US$9.71m). Minor Risk Revenue is less than US$5m (₹353m revenue, or US$4.2m).Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹155, the stock trades at a trailing P/E ratio of 62.9x. Average trailing P/E is 30x in the Chemicals industry in India.New Risk • Feb 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹827.4m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (₹827.4m market cap, or US$9.96m). Minor Risk Revenue is less than US$5m (₹353m revenue, or US$4.2m).Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹162, the stock trades at a trailing P/E ratio of 65.8x. Average trailing P/E is 29x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹127, the stock trades at a trailing P/E ratio of 70.2x. Average trailing P/E is 27x in the Chemicals industry in India.Reported Earnings • Sep 13Full year 2023 earnings released: EPS: ₹2.63 (vs ₹1.29 in FY 2022)Full year 2023 results: EPS: ₹2.63 (up from ₹1.29 in FY 2022). Revenue: ₹310.5m (up 62% from FY 2022). Net income: ₹11.4m (up 129% from FY 2022). Profit margin: 3.7% (up from 2.6% in FY 2022). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Sep 12Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹138, the stock trades at a trailing P/E ratio of 76.5x. Average trailing P/E is 28x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • Jul 10Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹126, the stock trades at a trailing P/E ratio of 70.1x. Average trailing P/E is 23x in the Chemicals industry in India.分析記事 • Jul 08Getting In Cheap On MCON Rasayan India Limited (NSE:MCON) Might Be DifficultWith a price-to-earnings (or "P/E") ratio of 66.8x MCON Rasayan India Limited ( NSE:MCON ) may be sending very bearish...Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹116, the stock trades at a trailing P/E ratio of 64.3x. Average trailing P/E is 21x in the Chemicals industry in India.Reported Earnings • May 31Full year 2023 earnings releasedFull year 2023 results: Revenue: ₹310.6m (up 62% from FY 2022). Net income: ₹11.4m (up 156% from FY 2022). Profit margin: 3.7% (up from 2.3% in FY 2022). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹54.95, the stock trades at a trailing P/E ratio of 78x. Average trailing P/E is 19x in the Chemicals industry in India.Board Change • Mar 21High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Director Tapas Majumdar was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.収支内訳MCON Rasayan India の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NSEI:MCON 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費30 Sep 255762392030 Jun 255422391031 Mar 255072390031 Dec 244862384030 Sep 244642478030 Jun 244432371031 Mar 244212264031 Dec 233871756030 Sep 233531647030 Jun 233311445031 Mar 233101141031 Mar 22192525031 Mar 2190215031 Mar 2090016031 Mar 197016031 Mar 184406031 Mar 1710020質の高い収益: MCON 非現金収入 のレベルが高いです。利益率の向上: MCONの現在の純利益率 (3.9%)は、昨年(5.2%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: MCONの収益は過去 5 年間で年間31.3%増加しました。成長の加速: MCONは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: MCONは過去 1 年間で収益成長率がマイナス ( -6% ) となったため、 Chemicals業界平均 ( 10.1% ) と比較することが困難です。株主資本利益率高いROE: MCONの 自己資本利益率 ( 6.6% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 05:32終値2026/05/22 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MCON Rasayan India Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 20MCON Rasayan India Limited to Report Second Half, 2026 Results on May 27, 2026MCON Rasayan India Limited announced that they will report second half, 2026 results on May 27, 2026
お知らせ • Nov 07MCON Rasayan India Limited to Report First Half, 2026 Results on Nov 12, 2025MCON Rasayan India Limited announced that they will report first half, 2026 results on Nov 12, 2025
Reported Earnings • Aug 23Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹421.3m (up 36% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.
Reported Earnings • May 27Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹425.4m (up 37% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.
Reported Earnings • Sep 13Full year 2023 earnings released: EPS: ₹2.63 (vs ₹1.29 in FY 2022)Full year 2023 results: EPS: ₹2.63 (up from ₹1.29 in FY 2022). Revenue: ₹310.5m (up 62% from FY 2022). Net income: ₹11.4m (up 129% from FY 2022). Profit margin: 3.7% (up from 2.6% in FY 2022). The increase in margin was driven by higher revenue.
Reported Earnings • May 31Full year 2023 earnings releasedFull year 2023 results: Revenue: ₹310.6m (up 62% from FY 2022). Net income: ₹11.4m (up 156% from FY 2022). Profit margin: 3.7% (up from 2.3% in FY 2022). The increase in margin was driven by higher revenue.
お知らせ • May 20MCON Rasayan India Limited to Report Second Half, 2026 Results on May 27, 2026MCON Rasayan India Limited announced that they will report second half, 2026 results on May 27, 2026
New Risk • May 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.9x net interest cover). High level of non-cash earnings (31% accrual ratio). Market cap is less than US$10m (₹410.8m market cap, or US$4.32m). Minor Risk Share price has been volatile over the past 3 months (8.7% average weekly change).
Valuation Update With 7 Day Price Move • May 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹56.05, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 29% over the past three years.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹45.70, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.
分析記事 • Feb 13MCON Rasayan India (NSE:MCON) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Valuation Update With 7 Day Price Move • Dec 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹72.60, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 65% over the past year.
お知らせ • Nov 07MCON Rasayan India Limited to Report First Half, 2026 Results on Nov 12, 2025MCON Rasayan India Limited announced that they will report first half, 2026 results on Nov 12, 2025
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹63.50, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 56% over the past year.
分析記事 • Sep 26Slammed 28% MCON Rasayan India Limited (NSE:MCON) Screens Well Here But There Might Be A CatchTo the annoyance of some shareholders, MCON Rasayan India Limited ( NSE:MCON ) shares are down a considerable 28% in...
Valuation Update With 7 Day Price Move • Sep 25Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹61.65, the stock trades at a trailing P/E ratio of 19.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 61% over the past year.
分析記事 • Sep 18Here's Why MCON Rasayan India (NSE:MCON) Has A Meaningful Debt BurdenThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
お知らせ • Sep 01MCON Rasayan India Limited, Annual General Meeting, Sep 25, 2025MCON Rasayan India Limited, Annual General Meeting, Sep 25, 2025, at 11:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹77.65, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 56% over the past year.
分析記事 • Aug 05Market Cool On MCON Rasayan India Limited's (NSE:MCON) Earnings Pushing Shares 25% LowerUnfortunately for some shareholders, the MCON Rasayan India Limited ( NSE:MCON ) share price has dived 25% in the last...
New Risk • Jun 03New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹834.4m (US$9.75m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). High level of non-cash earnings (45% accrual ratio). Market cap is less than US$10m (₹834.4m market cap, or US$9.75m). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding).
New Risk • Jun 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (₹924.5m market cap, or US$10.8m).
Valuation Update With 7 Day Price Move • May 30Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹126, the stock trades at a trailing P/E ratio of 38.3x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 16% over the past year.
New Risk • May 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (₹1.02b market cap, or US$12.0m).
Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹153, the stock trades at a trailing P/E ratio of 46.6x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 20% over the past year.
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹145, the stock trades at a trailing P/E ratio of 44x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 17% over the past year.
Board Change • Mar 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Tapas Majumdar was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Feb 07Is MCON Rasayan India (NSE:MCON) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
分析記事 • Dec 25Here's Why We Think MCON Rasayan India (NSE:MCON) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹191, the stock trades at a trailing P/E ratio of 49.9x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 22% over the past year.
Valuation Update With 7 Day Price Move • Nov 22Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹158, the stock trades at a trailing P/E ratio of 41.4x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 9.2% over the past year.
New Risk • Nov 21New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.11b market cap, or US$13.1m).
New Risk • Nov 06New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₹421m (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (30% accrual ratio). Minor Risks High level of debt (97% net debt to equity). Revenue is less than US$5m (₹421m revenue, or US$5.0m). Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).
Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹181, the stock trades at a trailing P/E ratio of 51x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 24% over the past year.
分析記事 • Oct 12The Price Is Right For MCON Rasayan India Limited (NSE:MCON) Even After Diving 27%The MCON Rasayan India Limited ( NSE:MCON ) share price has fared very poorly over the last month, falling by a...
分析記事 • Sep 25Here's Why We Think MCON Rasayan India (NSE:MCON) Is Well Worth WatchingIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Reported Earnings • Aug 23Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹421.3m (up 36% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.
お知らせ • Aug 20MCON Rasayan India Limited, Annual General Meeting, Sep 12, 2024MCON Rasayan India Limited, Annual General Meeting, Sep 12, 2024, at 11:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹182, the stock trades at a trailing P/E ratio of 51.3x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 72% over the past year.
分析記事 • Jun 23Is MCON Rasayan India (NSE:MCON) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
New Risk • Jun 14New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.8x net interest cover). Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (30% accrual ratio). Minor Risk Market cap is less than US$100m (₹904.6m market cap, or US$10.8m).
Reported Earnings • May 27Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹425.4m (up 37% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.
分析記事 • May 26MCON Rasayan India Limited (NSE:MCON) Not Lagging Market On Growth Or PricingMCON Rasayan India Limited's ( NSE:MCON ) price-to-earnings (or "P/E") ratio of 62.9x might make it look like a strong...
Valuation Update With 7 Day Price Move • May 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹106, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 14% over the past year.
New Risk • May 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (₹811.6m market cap, or US$9.71m). Minor Risk Revenue is less than US$5m (₹353m revenue, or US$4.2m).
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹155, the stock trades at a trailing P/E ratio of 62.9x. Average trailing P/E is 30x in the Chemicals industry in India.
New Risk • Feb 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹827.4m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (₹827.4m market cap, or US$9.96m). Minor Risk Revenue is less than US$5m (₹353m revenue, or US$4.2m).
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹162, the stock trades at a trailing P/E ratio of 65.8x. Average trailing P/E is 29x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹127, the stock trades at a trailing P/E ratio of 70.2x. Average trailing P/E is 27x in the Chemicals industry in India.
Reported Earnings • Sep 13Full year 2023 earnings released: EPS: ₹2.63 (vs ₹1.29 in FY 2022)Full year 2023 results: EPS: ₹2.63 (up from ₹1.29 in FY 2022). Revenue: ₹310.5m (up 62% from FY 2022). Net income: ₹11.4m (up 129% from FY 2022). Profit margin: 3.7% (up from 2.6% in FY 2022). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Sep 12Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹138, the stock trades at a trailing P/E ratio of 76.5x. Average trailing P/E is 28x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • Jul 10Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹126, the stock trades at a trailing P/E ratio of 70.1x. Average trailing P/E is 23x in the Chemicals industry in India.
分析記事 • Jul 08Getting In Cheap On MCON Rasayan India Limited (NSE:MCON) Might Be DifficultWith a price-to-earnings (or "P/E") ratio of 66.8x MCON Rasayan India Limited ( NSE:MCON ) may be sending very bearish...
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹116, the stock trades at a trailing P/E ratio of 64.3x. Average trailing P/E is 21x in the Chemicals industry in India.
Reported Earnings • May 31Full year 2023 earnings releasedFull year 2023 results: Revenue: ₹310.6m (up 62% from FY 2022). Net income: ₹11.4m (up 156% from FY 2022). Profit margin: 3.7% (up from 2.3% in FY 2022). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹54.95, the stock trades at a trailing P/E ratio of 78x. Average trailing P/E is 19x in the Chemicals industry in India.
Board Change • Mar 21High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Director Tapas Majumdar was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.